
<rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:media="http://search.yahoo.com/mrss/"  version="2.0">

<channel>
	<title>Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<description>Oncology News, Cancer Research &#38; Clinical Insights</description>
	<lastBuildDate>Thu, 22 Oct 2026 22:35:59 +0000</lastBuildDate>
	<language>en-US</language>
	<ttl>10</ttl>
	<copyright><![CDATA[P53 Inc.]]></copyright>
	<generator>Oncodaily.com</generator>
	<image>
		<url>https://oncodaily.com/pub/themes/oncodailynews/img/logo-ODN-round.png</url>
		<title>OncoDaily News</title>
		<link>https://oncodaily.com</link>
	</image>

	
<image>
	<url>https://oncodaily.com/pub/uploads/2025/10/OD-favicon-blank-320x320.webp</url>
	<title>Oncology News, Insights, Stories by OncoDaily</title>
	<link>https://oncodaily.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Anne-Claire Gerbaldi։ Three AI Announcements in a Week, One Vision for AI at AstraZeneca</title>
		<link>https://oncodaily.com/voices/anne-claire-gerbaldi-614633</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/1792652067866-1.webp" />
		<pubDate>Thu, 22 Oct 2026 22:35:59 +0000</pubDate>
		<guid isPermaLink="false">bc9df809213986623bcb553b04b2999c</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[OncoDaily AI]]></category>
		<category><![CDATA[AI]]></category>
		<category><![CDATA[Alaa Adel]]></category>
		<category><![CDATA[Anne-Claire Gerbaldi]]></category>
		<category><![CDATA[AstraZeneca]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Cardiomyopathies]]></category>
		<category><![CDATA[Daphne Koller]]></category>
		<category><![CDATA[David Dellamonica]]></category>
		<category><![CDATA[insitro]]></category>
		<category><![CDATA[Iskra Reic]]></category>
		<category><![CDATA[M42]]></category>
		<category><![CDATA[M42 Health]]></category>
		<category><![CDATA[MASH]]></category>
		<category><![CDATA[Nvidia]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Oracle Health]]></category>
		<category><![CDATA[Seema Verma]]></category>
		<category><![CDATA[Sferical AI]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/1792652067866-1.webp"/> <br/> <br/> Anne-Claire Gerbaldi, SVP, Chief Digital, Data and AI Officer at AstraZeneca, shared on LinkedIn: &#8220;Three AI announcements in a week, one vision for AI at AstraZeneca. Imagine what becomes possible [&#8230;]]]></description>
							</item>
		<item>
		<title>Elizabeth Smyth: ESMO Updates Clinical Practice Guidelines for Gastric and Oesophageal Cancer</title>
		<link>https://oncodaily.com/voices/elizabeth-smyth-614632</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/daa0ab77-c2ff-46fd-8fd8-77d08422ad16-1280x720.webp" />
		<pubDate>Thu, 22 Oct 2026 22:28:27 +0000</pubDate>
		<guid isPermaLink="false">300cd603a97b1df7e252a1d2d9762abc</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Elizabeth Smyth]]></category>
		<category><![CDATA[ESMO]]></category>
		<category><![CDATA[gastric cancer]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/daa0ab77-c2ff-46fd-8fd8-77d08422ad16-1280x720.webp"/> <br/> <br/> Elizabeth Smyth, ESMO Director of Education, Clinical Lead at the Oxford Clinical Trials Office, shared a post on LinkedIn: &#8220;Really proud to have co-authored the newly published ESMO Clinical Practice [&#8230;]]]></description>
							</item>
		<item>
		<title>JJ Singleton Shares Experience at PCORI Annual Meeting and Highlights Lessons From Patient-Centered Clinical Research</title>
		<link>https://oncodaily.com/voices/jj-singleton-614615</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/08/a2fc6165fdc44322894ecdbfad1d6f27-1.webp" />
		<pubDate>Thu, 22 Oct 2026 22:20:50 +0000</pubDate>
		<guid isPermaLink="false">ecbe4aa1dbb7ab6c1d19d48489c96347</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Ben White]]></category>
		<category><![CDATA[Brooke Lamm]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[JJ Singleton]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Patient-Centered Outcomes Research Institute]]></category>
		<category><![CDATA[PCORI]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/08/a2fc6165fdc44322894ecdbfad1d6f27-1.webp"/> <br/> <br/> JJ Singleton, Research Advocate at Fight Colorectal Cancer, shared on LinkedIn: &#8220;DC it&#8217;s been fun but time to head home and rest up before heading to Denver on November 1st․ [&#8230;]]]></description>
							</item>
		<item>
		<title>Federica Miglietta: CNS and Leptomeningeal Involvement in Advanced Breast Cancer</title>
		<link>https://oncodaily.com/voices/federica-miglietta-614618</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/816935cc-31dd-47cd-87e5-b1a95252ec63-1280x720.webp" />
		<pubDate>Thu, 22 Oct 2026 22:20:38 +0000</pubDate>
		<guid isPermaLink="false">17012e0e8758d98f30b3cf874658583e</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[A. Botticelli]]></category>
		<category><![CDATA[A. Vingiani]]></category>
		<category><![CDATA[A.P. Dei Tos]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[C. Vernieri]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[D. Palleschi]]></category>
		<category><![CDATA[E. Di Liso]]></category>
		<category><![CDATA[F. Miglietta]]></category>
		<category><![CDATA[F. Piacentini]]></category>
		<category><![CDATA[Federica Miglietta]]></category>
		<category><![CDATA[G. Fotia]]></category>
		<category><![CDATA[G. Griguolo]]></category>
		<category><![CDATA[G. Landa]]></category>
		<category><![CDATA[G. Pruneri]]></category>
		<category><![CDATA[G.M. Vernaci]]></category>
		<category><![CDATA[L. Casadei]]></category>
		<category><![CDATA[M. Bottosso]]></category>
		<category><![CDATA[M. Cacciatore]]></category>
		<category><![CDATA[M.V. Dieci]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[P. Napolitano]]></category>
		<category><![CDATA[T. Giarratano]]></category>
		<category><![CDATA[University of Padua]]></category>
		<category><![CDATA[V. Guarneri]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/816935cc-31dd-47cd-87e5-b1a95252ec63-1280x720.webp"/> <br/> <br/> Federica Miglietta, Medical Oncologist, Researcher at Department of Surgery, Oncology and Gastroenterology at University of Padova, shared a post on LinkedIn: &#8220;Pleased to share our new study in ESMO Open [&#8230;]]]></description>
							</item>
		<item>
		<title>Could AI Help Predict Breast Cancer Risk Years Before a Diagnosis? &#8211; BCRF</title>
		<link>https://oncodaily.com/voices/bcrf-614612</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/07/7cb5184e44544b3f8ef3c504c293b06e.webp" />
		<pubDate>Thu, 22 Oct 2026 22:11:39 +0000</pubDate>
		<guid isPermaLink="false">1f2114afa071a40a6d2ee329610ad290</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[BCRF]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Constance Lehman]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[The Breast Cancer Research Foundation]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/07/7cb5184e44544b3f8ef3c504c293b06e.webp"/> <br/> <br/> The Breast Cancer Research Foundation &#8211; BCRF shared a post on LinkedIn: &#8220;Could AI help predict breast cancer risk years before a diagnosis? As The New York Times reports, AI [&#8230;]]]></description>
							</item>
		<item>
		<title>ESMO Introduces Updated ESCAT v2 Framework to Guide Precision Oncology Treatment Decisions</title>
		<link>https://oncodaily.com/voices/esmo-614606</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/esmo-1-1-2.webp" />
		<pubDate>Thu, 22 Oct 2026 22:07:09 +0000</pubDate>
		<guid isPermaLink="false">8d896f7d804f09281e364265352a95ac</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[ESCAT]]></category>
		<category><![CDATA[ESCAT v2]]></category>
		<category><![CDATA[ESMO]]></category>
		<category><![CDATA[ESMO Scale for Clinical Actionability of molecular Targets]]></category>
		<category><![CDATA[European Society for Medical Oncology]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Precision Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/esmo-1-1-2.webp"/> <br/> <br/> ESMO &#8211; European Society for Medical Oncology shared on LinkedIn: &#8220;Precision Oncology is generating an increasing volume and diversity of biomarker information, making treatment decisions more complex than ever. The [&#8230;]]]></description>
							</item>
		<item>
		<title>Vivek Subbiah: Joining the International Alliance for Personalised Medicine Event at ESMO 2026</title>
		<link>https://oncodaily.com/voices/vivek-subbiah-614602</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/09/424B8FFB-80E9-4A8E-A3C4-679D0A87BDB2-1280x720.webp" />
		<pubDate>Thu, 22 Oct 2026 21:53:45 +0000</pubDate>
		<guid isPermaLink="false">e3405e6e064d66f0cb90d6de634780c4</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[ESMO]]></category>
		<category><![CDATA[ESMO2026]]></category>
		<category><![CDATA[ESMO26]]></category>
		<category><![CDATA[International Alliance for Personalised Medicine Alliance]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[Vivek Subbiah]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/09/424B8FFB-80E9-4A8E-A3C4-679D0A87BDB2-1280x720.webp"/> <br/> <br/> Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on LinkedIn: &#8220;Mark your calenders and register for an event around ESMO 2026 Meeting, Madrid, Spain. [&#8230;]]]></description>
							</item>
		<item>
		<title>Congratulations to the Newly Elected Leadership of the UICC &#8211; IGCS</title>
		<link>https://oncodaily.com/career/igcs-614589</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/BeFunky-collage-2026-10-23T013859.344-1-1280x720.webp" />
		<pubDate>Thu, 22 Oct 2026 21:43:03 +0000</pubDate>
		<guid isPermaLink="false">27e1a192a5031aedf0685a6dd59f29c5</guid>
				<category><![CDATA[Career Updates]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[CS Pramesh]]></category>
		<category><![CDATA[IGCS]]></category>
		<category><![CDATA[Kathleen Schmeler]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
		<category><![CDATA[UICC]]></category>
		<category><![CDATA[Union for International Cancer Control]]></category>
		<category><![CDATA[Zainab Shinkafi-Bagudu]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/BeFunky-collage-2026-10-23T013859.344-1-1280x720.webp"/> <br/> <br/> IGCS shared on X: &#8220;Congratulations to the newly elected leadership of the Union for International Cancer Control (UICC). We extend our warmest congratulations to incoming President Dr. Zainab Shinkafi-Bagudu, President-elect [&#8230;]]]></description>
							</item>
		<item>
		<title>Humaid Al-Shamsi: Leading Arab Participation at ESMO 2026 With Nine Cancer Research Papers</title>
		<link>https://oncodaily.com/voices/humaid-al-shamsi-614597</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/HVNu4aqXAAArXQc-1280x720.webp" />
		<pubDate>Thu, 22 Oct 2026 21:36:54 +0000</pubDate>
		<guid isPermaLink="false">a8788269e15b9923081295b67a40a75d</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[Burjeel Oncology Institute]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[ESMO]]></category>
		<category><![CDATA[esmo 2026]]></category>
		<category><![CDATA[ESMO26]]></category>
		<category><![CDATA[Humaid Al-Shamsi]]></category>
		<category><![CDATA[Nexomic]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/HVNu4aqXAAArXQc-1280x720.webp"/> <br/> <br/> Humaid Al-Shamsi, The Chairman of Nexomic, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on X: &#8220;To Madrid to participate in the largest European cancer conference, proud to [&#8230;]]]></description>
							</item>
		<item>
		<title>Carmen Monge-Montero: Bringing More Lived Experience Perspectives Into the Conversation at ESMO 2026</title>
		<link>https://oncodaily.com/voices/carmen-monge-montero-614592</link>
		<media:thumbnail url="https://oncodaily.com/pub/uploads/2026/10/cf3be485-8bad-4e9b-8861-972b8180a813-1280x720.webp" />
		<pubDate>Thu, 22 Oct 2026 21:28:50 +0000</pubDate>
		<guid isPermaLink="false">eab6c67d3a79e2fb7c4ad29b161c91f1</guid>
				<category><![CDATA[Voices]]></category>
		<category><![CDATA[cancer]]></category>
		<category><![CDATA[Carmen Monge-Montero]]></category>
		<category><![CDATA[esmo 2026]]></category>
		<category><![CDATA[ESMO26]]></category>
		<category><![CDATA[OncoDaily]]></category>
		<category><![CDATA[Oncology]]></category>
					<description><![CDATA[<img src="https://oncodaily.com/pub/uploads/2026/10/cf3be485-8bad-4e9b-8861-972b8180a813-1280x720.webp"/> <br/> <br/> Carmen Monge-Montero, Lead of the OncoDaily Lived Experience Advocacy Hub, Researcher and Global Cancer Advocate, shared on LinkedIn: &#8220;Hola ESMO!  Looking forward to seeing familiar faces, meeting new advocates, and [&#8230;]]]></description>
							</item>
	</channel>
</rss>
